Optogenetic MRI Neural Circuit Mapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current blood oxygenation level-dependent functional magnetic resonance imaging (BOLD fMRI) technologies face challenges in understanding the neural circuits that trigger BOLD signals, which complicates the interpretation and application of fMRI in diagnosing neurological disorders and screening therapeutic agents.
Innovation Solution
The integration of optogenetic modification using light-activated molecules, such as opsins, into specific neural cell types within the brain, allowing for millisecond-scale targeted activity modulation and the use of high-field fMRI to map neural responses and connectivity patterns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If BOLD fMRI is used for whole brain imaging, then non-invasive imaging capability is achieved, but the neural circuits that trigger BOLD signals cannot be fully understood
Solution Approach 1:
The patent segments the brain into specific neural cell populations that can be genetically targeted. By using cell-type-specific promoters to drive light-responsive molecule expression in particular neuronal populations, the method divides the complex whole-brain imaging problem into tractable components that can be individually manipulated and observed via fMRI, thereby recovering neural circuit information while maintaining non-invasive imaging.
Solution Approach 2:
The patent introduces light-responsive molecules (opsins) as an intermediary between optical stimulation and neural activity detection. These molecules serve as a bridge that allows external light control of specific neural populations and simultaneous fMRI detection of the resulting neural and hemodynamic responses, enabling circuit-level understanding without invasive electrodes.
2Measurement precision
If light-responsive molecules are introduced into specific cell types, then targeted activity modulation is achieved, but device complexity increases
Solution Approach 1:
The patent replaces traditional mechanical/electrical stimulation methods with optical control mechanisms. By using light-responsive molecules that can be activated by specific wavelengths of light, the system achieves precise temporal and spatial control of neural activity without physical contact or invasive electrodes, substituting mechanical stimulation with optical field-based control.
Solution Approach 2:
The patent exploits parameter changes in the optical domain to control neural activity. By varying light wavelength, intensity, and timing parameters, the system can selectively activate or inhibit specific neural populations expressing different optogenetic tools (e.g., Channelrhodopsin for excitation, Halorhodopsin for inhibition), achieving precise targeted modulation through non-invasive optical parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the visualization of causal effects of specific cell types and their projections, providing insights into the neural circuits involved in BOLD signal generation and facilitating the diagnosis of neurological disorders and the evaluation of therapeutic agents.
Implementation Method 1
modifying a target neural cell population in a first region of a brain to express light-responsive molecules. Using a light pulse, the light-responsive molecules in the target neural cell population are stimulated
Implementation Method 2
Blood oxygenation level-dependent functional magnetic resonance imaging (BOLD fMRI) is a widely used technology for non-invasive whole brain imaging. BOLD signals reflect complex changes in cerebral blood flow (CBF), cerebral blood volume (CBV), and cerebral metabolic rate of oxygen consumption (CMRO2) following neuronal activity
Data Source
AI summary
Disclosed herein are systems and methods involving the use of magnetic resonance imaging and optogenetic neural stimulation. Aspects of the disclosure include modifying a target neural cell population in a first region of a brain to express light-responsive molecules. Using a light pulse, the light-responsive molecules in the target neural cell population are stimulated. Multiple regions of the brain are scanned via magnetic resonance imaging. The scans allow for observation of a neural reaction in response to the stimulation in at least one of the multiple regions of the brain.